Exhibiting at VIV Asia 2025

San Heh Pharmaceutical Corporation STSP Branch is a Taiwan-based veterinary pharmaceutical manufacturing company operating under the San Heh Group. Strategically located in Kaohsiung City within the Southern Taiwan Science Park (STSP), the branch specializes in the production of high-quality veterinary medicines, addressing the growing global demand for safe, effective, and compliant animal health solutions.

Core Business and Offerings

San Heh Pharmaceutical Corporation STSP Branch is primarily engaged in the research, development, manufacturing, and global distribution of veterinary pharmaceutical products. The company's offerings are designed to meet the needs of livestock producers, veterinary practitioners, and distributors across Asia, the Middle East, Africa, and Latin America.

The core product lines include:

• Injectable Antibiotics:

  • Amoxicillin
  • Ampicillin
  • Ceftiofur

• Oral Solutions:

  • Doxycycline
  • Tiamulin

• Medicated Powders:

  • Florfenicol
  • Lincomycin-Spectinomycin

These products are formulated to treat a wide range of bacterial infections in poultry, swine, and cattle, supporting animal welfare and farm productivity.

Specialization and Core USP

San Heh Pharmaceutical’s core strength lies in its compliance-driven manufacturing capabilities and its focus on injectable veterinary antibiotics, a niche requiring strict regulatory adherence and advanced formulation technologies. Their facilities are designed to meet GMP (Good Manufacturing Practice) standards, ensuring product consistency and safety.

The company's location in the Southern Taiwan Science Park (STSP) provides access to modern infrastructure, research institutions, and export facilitation, enhancing its ability to innovate and scale effectively. The branch specializes in sterile manufacturing, with a clean-room environment certified to pharmaceutical-grade production standards.

Financial Performance

As a private company, San Heh Pharmaceutical does not publish detailed financial statements. However, based on Taiwan’s business registration and export statistics:

• Estimated annual revenue exceeds $10 million USD, with growth driven by expanding export contracts.
• The company allocates approximately 12% of its annual revenue to R&D, focusing on new formulations and regulatory submissions for global markets.

Shipment Records

From publicly accessible trade databases including ImportYeti and Taiwanese customs records:

• San Heh Pharmaceutical has shipped to over 18 countries including Egypt, Pakistan, Indonesia, Vietnam, Nigeria, and Peru.
• Average export volume exceeds 120 shipments per year, primarily of injectable antibiotics and water-soluble oral treatments.
• High-frequency products shipped include Ceftiofur Injection (100 mg/mL) and Florfenicol 20% Powder.
• Major clients include veterinary distributors and large-scale poultry integrators.

Target Market

San Heh’s customer base spans across:

• Livestock producers (poultry, swine, ruminants)
• Veterinary wholesalers and distributors
• Feed mills and integrators
• Private and government veterinary health programs

The company focuses heavily on price-sensitive and regulation-light markets in developing countries, offering competitive alternatives to multinational pharma brands without compromising on efficacy or safety.

Capabilities

• GMP-certified sterile and non-sterile production lines
• Integrated formulation, filling, and packaging facilities
• Dedicated R&D labs for antibiotic resistance studies
• Batch traceability and cold-chain export systems
• Private-label and contract manufacturing options

The company can scale production for large-volume orders and is capable of adjusting formulations for market-specific regulatory requirements.

Certifications and Compliance

• Taiwan FDA Veterinary GMP Certification
• ISO 9001:2015 Quality Management
• Registered products under the Bureau of Animal and Plant Health Inspection and Quarantine (BAPHIQ)
• Ongoing registration approvals in Southeast Asia and Africa
• Compliance with ASEAN harmonized standards for veterinary medicines

Customer Testimonials

“Reliable injectable antibiotics with consistent performance. San Heh products are crucial to our poultry operations in Egypt.”
– Dr. Mahmoud El-Sabry, Veterinary Consultant, Cairo

“Their Florfenicol and Doxycycline are among the best-priced, high-quality products we’ve sourced from Asia.”
– Pedro Garcia, Animal Health Importer, Peru

Major Achievements

• Expanded sterile production capacity by 40% in 2022 to meet growing export demands.
• Received a Taiwan Excellence Award nomination for its advanced injectable formulations.
• Secured exclusive distribution agreements in 8 new international markets between 2021 and 2023.
• Participated in global veterinary trade expos including VIV Asia and ILDEX Vietnam.

San Heh Pharmaceutical Corporation STSP Branch continues to build its reputation as a reliable and cost-effective source of veterinary pharmaceutical products, combining technical expertise with global compliance to serve evolving animal health needs worldwide.